Clinical Manifestations and Pathogenesis of Dialysis‐Related Amyloidosis
- 1 July 1996
- journal article
- Published by Wiley in Seminars in Dialysis
- Vol. 9 (4) , 360-368
- https://doi.org/10.1111/j.1525-139x.1996.tb00699.x
Abstract
No abstract availableThis publication has 93 references indexed in Scilit:
- An estimate of β2-microglobulin deposition rate in uremic patients on hemodialysis using a mathematical kinetic modelKidney International, 1995
- Role of IL-1β and prostaglandins in β2-microglobulin-induced bone mineral dissolutionKidney International, 1995
- β2-Microglobulin Modified with Advanced Glycation End Products Induces Interleukin-6 from Human Macrophages: Role in the Pathogenesis of Hemodialysis-Associated AmyloidosisBiochemical and Biophysical Research Communications, 1994
- Purification and complete amino acid sequence of novel β2-microglobulinBiochemical and Biophysical Research Communications, 1990
- Different Handling of Beta2-Microglobulin during Hemodialysis and HemofiltrationNephron, 1988
- HAEMODIALYSIS MEMBRANES, SERUM β2-MICROGLOBULIN, AND DIALYSIS AMYLOIDOSISThe Lancet, 1986
- Serum Levels of β2-Microglobulin as a New Form of Amyloid Protein in Patients Undergoing Long-Term HemodialysisNew England Journal of Medicine, 1986
- In vitro formation of amyloid fibrils from intact β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- Serum β2-Microglobulin in Hemodialyzed PatientsNephron, 1978